Sequential multimodal therapy in chronic thromboembolic pulmonary hypertension with mixed anatomical lesions: a proof of concept

Extract
Three treatment options have been successfully developed for the management of chronic thromboembolic pulmonary hypertension (CTEPH): pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA) and pulmonary arterial hypertension (PAH)-targeted medical therapy [1–3]. Management of CTEPH has greatly evolved in the past decade, with the possibility to combine these therapeutic options [4, 5].

Source: European Respiratory Journal - November 2, 2023 Category: Respiratory Medicine Authors: Jevnikar, M., Solinas, S., Brenot, P., Lechartier, B., Kularatne, M., Montani, D., Savale, L., Garcia-Alonso, C., Sitbon, O., Beurnier, A., Boucly, A., Bulifon, S., Seferian, A., Roche, A., Mercier, O., Simonneau, G., Fadel, E., Humbert, M., Jaïs, Tags: Pulmonary vascular disease Research Letters Source Type: research